Trial Profile
A Randomised, Double-blind, Placebo-controlled, Three-way Crossover, Repeat Dose Pilot Study Comparing the Effect of Inhaled Fluticasone Furoate/GW642444M Combination and Fluticasone Furoate on the Allergen-induced Early Asthmatic Response in Subjects With Mild Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Sep 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary) ; Vilanterol/fluticasone furoate
- Indications Asthma
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Sponsors GSK
- 20 May 2012 Results reported at the 108th International Conference of the American Thoracic Society.
- 17 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 17 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.